Stefanie Lanzinger

1.5k total citations
74 papers, 845 citations indexed

About

Stefanie Lanzinger is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Stefanie Lanzinger has authored 74 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Endocrinology, Diabetes and Metabolism, 27 papers in Genetics and 24 papers in Surgery. Recurrent topics in Stefanie Lanzinger's work include Diabetes Management and Research (39 papers), Diabetes and associated disorders (27 papers) and Diabetes Treatment and Management (26 papers). Stefanie Lanzinger is often cited by papers focused on Diabetes Management and Research (39 papers), Diabetes and associated disorders (27 papers) and Diabetes Treatment and Management (26 papers). Stefanie Lanzinger collaborates with scholars based in Germany, Austria and United States. Stefanie Lanzinger's co-authors include Reinhard W. Holl, Thomas Reinehr, Nina Lass, Annette Peters, Alexandra Schneider, Susanne Breitner, Juliane Rothermel, Josef Cyrys, Peter Bramlage and Thomas Danne and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Stefanie Lanzinger

67 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stefanie Lanzinger Germany	16	350	253	163	141	132	74	845
Mervi Oikonen Finland	16	130 0.4×	121 0.5×	57 0.3×	79 0.6×	288 2.2×	29	1.1k
Mouloud Agajani Delavar Iran	18	128 0.4×	76 0.3×	29 0.2×	91 0.6×	241 1.8×	69	812
Qin Xu China	18	139 0.4×	549 2.2×	21 0.1×	42 0.3×	85 0.6×	75	1.2k
Kathy Bean France	19	211 0.6×	151 0.6×	22 0.1×	74 0.5×	313 2.4×	27	1.4k
Sara R. Adams United States	16	146 0.4×	97 0.4×	33 0.2×	35 0.2×	180 1.4×	61	826
Marian Renvall United States	19	276 0.8×	132 0.5×	137 0.8×	55 0.4×	126 1.0×	33	1.1k
Teresa Tamayo Germany	16	265 0.8×	68 0.3×	81 0.5×	53 0.4×	184 1.4×	21	728
Charlotte Cerqueira Denmark	14	526 1.5×	34 0.1×	94 0.6×	85 0.6×	111 0.8×	24	977
V. L. S. Crawford United Kingdom	15	67 0.2×	573 2.3×	18 0.1×	80 0.6×	67 0.5×	26	1.1k
Laurence Mandereau-Bruno France	9	91 0.3×	428 1.7×	33 0.2×	24 0.2×	24 0.2×	23	693

Countries citing papers authored by Stefanie Lanzinger

Since Specialization

Citations

This map shows the geographic impact of Stefanie Lanzinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Lanzinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Lanzinger more than expected).

Fields of papers citing papers by Stefanie Lanzinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Lanzinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Lanzinger. The network helps show where Stefanie Lanzinger may publish in the future.

Co-authorship network of co-authors of Stefanie Lanzinger

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Lanzinger. A scholar is included among the top collaborators of Stefanie Lanzinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Lanzinger. Stefanie Lanzinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bramlage, Peter, et al.. (2025). Comparative analysis on renal and cardiovascular outcomes of antidiabetic treatment in chronic kidney disease patients—A systematic review and network meta‐analysis. Diabetes Obesity and Metabolism. 27(11). 6254–6263.

Zareini, Bochra, Ulrik Pedersen‐Bjergaard, Mikkel Porsborg Andersen, et al.. (2025). Type 2 diabetes, sodium-glucose cotransporter-2 inhibitors and cardiovascular outcomes: real world evidence versus a randomised clinical trial. Cardiovascular Diabetology. 24(1). 371–371.

Chen, Ying, Andrea Schlotterer, Nadine Dietrich, et al.. (2024). Sex differences in the development of experimental diabetic retinopathy. Scientific Reports. 14(1). 22812–22812. 3 indexed citations

Lanzinger, Stefanie, Saketh Rompicherla, Grenye O’Malley, et al.. (2024). 1456-P: Type 1 Diabetes Care and Device Use in Older Adults—Transatlantic Comparison Based on T1DX-QI and DPV Registries. Diabetes. 73(Supplement_1). 1 indexed citations

Lanzinger, Stefanie, Torben Biester, Erhard Siegel, et al.. (2023). The impact of daily mean air temperature on the proportion of time in hypoglycemia in 2,582 children and adolescents with type 1 diabetes – Is this association clinically relevant?. Environmental Research. 233. 116488–116488. 1 indexed citations

Auzanneau, Marie, Alexander J. Eckert, Andreas Fritsche, et al.. (2023). Diabetes in all hospitalized cases in Germany 2015–2019 and impact of the first COVID-19 year 2020. Endocrine Connections. 12(4).

Dovč, Klemen, Stefanie Lanzinger, Roque Cardona‐Hernandez, et al.. (2023). Association of Achieving Time in Range Clinical Targets With Treatment Modality Among Youths With Type 1 Diabetes. JAMA Network Open. 6(2). e230077–e230077. 23 indexed citations

Chobot, Agata, Stefanie Lanzinger, Hessa Alkandari, et al.. (2023). Diabetes care practices and outcomes in 40.000 children and adolescents with type 1 diabetes from the SWEET registry during the COVID-19 pandemic. Diabetes Research and Clinical Practice. 202. 110809–110809. 3 indexed citations

Lal, Rayhan, Stefanie Lanzinger, Kellee M. Miller, et al.. (2022). Temporal Changes in Hemoglobin A1c and Diabetes Technology Use in DPV, NPDA, and T1DX Pediatric Cohorts from 2010 to 2018. Diabetes Technology & Therapeutics. 24(9). 628–634. 9 indexed citations

10.

Kamrath, Clemens, Kirsten Minden, Susanna Wiegand, et al.. (2022). Access to Healthcare for Children and Adolescents with a Chronic Health Condition during the COVID-19 Pandemic: First Results from the KICK-COVID Study in Germany. Children. 10(1). 10–10. 5 indexed citations

11.

DeSalvo, Daniel J., Stefanie Lanzinger, Nudrat Noor, et al.. (2022). Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement Collaborative. Diabetes Technology & Therapeutics. 24(12). 920–924. 16 indexed citations

12.

Lanzinger, Stefanie, F. Best, Tanja Bergmann, et al.. (2022). Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring. Diabetes Technology & Therapeutics. 24(10). 763–769. 6 indexed citations

13.

Bramlage, Peter, Stefanie Lanzinger, Sascha R. Tittel, et al.. (2021). Guidelines adherence in the prevention and management of chronic kidney disease in patients with diabetes mellitus on the background of recent European recommendations – a registry-based analysis. BMC Nephrology. 22(1). 184–184. 21 indexed citations

14.

Danne, Thomas, Stefanie Lanzinger, Martin de Bock, et al.. (2021). A Worldwide Perspective on COVID-19 and Diabetes Management in 22,820 Children from the SWEET Project: Diabetic Ketoacidosis Rates Increase and Glycemic Control Is Maintained. Diabetes Technology & Therapeutics. 23(9). 632–641. 27 indexed citations

15.

Alonso, G. Todd, Erick Richmond, Stéphane Besançon, et al.. (2020). Worldwide differences in childhood type 1 diabetes: The SWEET experience. Pediatric Diabetes. 22(2). 207–214. 18 indexed citations

16.

Klingensmith, Georgeanna J., Stefanie Lanzinger, William V. Tamborlane, et al.. (2018). Adolescent type 2 diabetes: Comparing the Pediatric Diabetes Consortium and Germany/Austria/Luxemburg Pediatric Diabetes Prospective registries. Pediatric Diabetes. 19(7). 1156–1163. 15 indexed citations

17.

Auzanneau, Marie, Stefanie Lanzinger, Barbara Bohn, et al.. (2018). Area Deprivation and Regional Disparities in Treatment and Outcome Quality of 29,284 Pediatric Patients With Type 1 Diabetes in Germany: A Cross-sectional Multicenter DPV Analysis. Diabetes Care. 41(12). 2517–2525. 40 indexed citations

18.

Lanzinger, Stefanie, Joachim Rosenbauer, Dorothea Sugiri, et al.. (2018). Impact of long-term air pollution exposure on metabolic control in children and adolescents with type 1 diabetes: results from the DPV registry. Diabetologia. 61(6). 1354–1361. 23 indexed citations

19.

Lanzinger, Stefanie, Alexandra Schneider, Susanne Breitner, et al.. (2016). Ultrafine and Fine Particles and Hospital Admissions in Central Europe. Results from the UFIREG Study. American Journal of Respiratory and Critical Care Medicine. 194(10). 1233–1241. 54 indexed citations

20.

Dostál, Miroslav, Anna Pastorková, Stefanie Lanzinger, et al.. (2015). [Health effects of ambient ultrafine particles--the project UFIREG].. PubMed. 154(4). 176–80. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact